[HTML][HTML] Neuroprotective and antioxidant properties of CholesteroNitrone ChN2 and QuinolylNitrone QN23 in an experimental model of cerebral ischemia …
B Chamorro, S Izquierdo-Bermejo… - Antioxidants, 2023 - mdpi.com
Ischemic stroke is the leading cause of disability and the second leading cause of death
worldwide. However, current therapeutic strategies are scarce and of limited efficacy. The …
worldwide. However, current therapeutic strategies are scarce and of limited efficacy. The …
Neuroprotective and Antioxidant Properties of CholesteroNitrone ChN2 and QuinolylNitrone QN23 in an Experimental Model of Cerebral Ischemia: Involvement of …
B Chamorro, S Izquierdo-Bermejo… - Antioxidants (Basel …, 2023 - pubmed.ncbi.nlm.nih.gov
Ischemic stroke is the leading cause of disability and the second leading cause of death
worldwide. However, current therapeutic strategies are scarce and of limited efficacy. The …
worldwide. However, current therapeutic strategies are scarce and of limited efficacy. The …
Neuroprotective and Antioxidant Properties of CholesteroNitrone ChN2 and QuinolylNitrone QN23 in an Experimental Model of Cerebral Ischemia: Involvement of …
B Chamorro, S Izquierdo-Bermejo… - Antioxidants (Basel …, 2023 - europepmc.org
Ischemic stroke is the leading cause of disability and the second leading cause of death
worldwide. However, current therapeutic strategies are scarce and of limited efficacy. The …
worldwide. However, current therapeutic strategies are scarce and of limited efficacy. The …
Neuroprotective and Antioxidant Properties of CholesteroNitrone ChN2 and QuinolylNitrone QN23 in an Experimental Model of Cerebral Ischemia: Involvement of …
B Chamorro, S Izquierdo-Bermejo… - …, 2023 - search.ebscohost.com
Ischemic stroke is the leading cause of disability and the second leading cause of death
worldwide. However, current therapeutic strategies are scarce and of limited efficacy. The …
worldwide. However, current therapeutic strategies are scarce and of limited efficacy. The …
[HTML][HTML] Neuroprotective and Antioxidant Properties of CholesteroNitrone ChN2 and QuinolylNitrone QN23 in an Experimental Model of Cerebral Ischemia …
B Chamorro, S Izquierdo-Bermejo… - …, 2023 - ncbi.nlm.nih.gov
Ischemic stroke is the leading cause of disability and the second leading cause of death
worldwide. However, current therapeutic strategies are scarce and of limited efficacy. The …
worldwide. However, current therapeutic strategies are scarce and of limited efficacy. The …
Neuroprotective and Antioxidant Properties of CholesteroNitrone ChN2 and QuinolylNitrone QN23 in an Experimental Model of Cerebral Ischemia: Involvement of …
B Chamorro, S Izquierdo-Bermejo… - …, 2023 - search.proquest.com
Ischemic stroke is the leading cause of disability and the second leading cause of death
worldwide. However, current therapeutic strategies are scarce and of limited efficacy. The …
worldwide. However, current therapeutic strategies are scarce and of limited efficacy. The …
[引用][C] Neuroprotective and Antioxidant Properties of CholesteroNitrone ChN2 and QuinolylNitrone QN23 in an Experimental Model of Cerebral Ischemia: Involvement …
B Chamorro, S Izquierdo-Bermejo… - …, 2023 - produccioncientifica.ucm.es
Neuroprotective and Antioxidant Properties of CholesteroNitrone ChN2 and QuinolylNitrone QN23 in an Experimental Model of Cerebral Ischemia: Involvement of …
B Chamorro, S Izquierdo-Bermejo… - 2023 - digital.csic.es
Ischemic stroke is the leading cause of disability and the second leading cause of death
worldwide. However, current therapeutic strategies are scarce and of limited efficacy. The …
worldwide. However, current therapeutic strategies are scarce and of limited efficacy. The …